BioMarin Pharmaceutical Inc. buy Piper Sandler
Start price
23.02.24
/
50%
€84.34
Target price
23.02.25
€98.83
Performance (%)
-10.32%
Price
26.04.24
€75.64
Summary
This prediction is currently active. The price of BioMarin Pharmaceutical Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -10.32%. This prediction currently runs until 23.02.25. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
BioMarin Pharmaceutical Inc. | -10.633% | -10.633% |
iShares Core DAX® | 2.594% | -1.861% |
iShares Nasdaq 100 | 3.553% | -2.064% |
iShares Nikkei 225® | 0.687% | -8.704% |
iShares S&P 500 | 2.209% | -1.988% |
Comments by Piper_Sandler for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Piper Sandler from $115.00 to $107.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat